Comprehensive analysis of SBI Innovative Opportunities Fund - Direct (G) (44989) providing detailed insights into fund performance, portfolio holdings, risk metrics, expense ratios, and investment recommendations.
SBI Funds Management Ltd
The investment objective of the scheme is to provide investors with opportunities for long term capital appreciation by investing in equity and equity related instruments of companies that seeks to benefit from adoption of innovative strategies & theme. However, there is no assurance that the investment objective of the scheme will be achieved.
A comprehensive at-a-glance view of key mutual fund health indicators
Weak Returns
High Risk
Low Expense Ratio
Equity Focused
New Team
Neutral Fit
Showing 1Y NAV history
Performance across different time periods
Fund shows mixed signals. Consider your investment timeline and risk tolerance.
Review detailed analysis and consider dollar-cost averaging through SIPs.
Fund shows mixed signals. Consider your investment timeline and risk tolerance.
Review detailed analysis and consider dollar-cost averaging through SIPs.
Recent performance momentum
Outperformance vs benchmark
Market exposure level
Fund management costs
Assets under management
Risk-adjusted returns
Fund manager experience
Historical performance consistency
This fund has underperformed its benchmark by 4.81% over the 3Y period.
See how your money can grow and compare with popular investment options
Disclaimer: Returns are illustrative and based on assumed rates. Mutual fund investments are subject to market risk. Please read scheme documents carefully.
| Company | Sector | % Assets |
|---|---|---|
| Eternal Ltd | E-Commerce/App based Aggregator | 7.98% |
| TBO Tek Ltd | E-Commerce/App based Aggregator | 6.35% |
| Zinka Logistics Solutions Ltd | Logistics | 5.66% |
| Divis Laboratories Ltd | Pharmaceuticals | 5.37% |
| Nazara Technologies Ltd | E-Commerce/App based Aggregator | 4.69% |
| Route Mobile Ltd | IT - Software | 4.56% |
| Happiest Minds Technologies Ltd | IT - Software | 4.09% |
| Abbott India Ltd | Pharmaceuticals | 4.06% |
| Lupin Ltd | Pharmaceuticals | 4.01% |
| Firstsource Solutions Ltd | IT - Software | 3.99% |
Compare against Sectoral / Thematic category average
This comparison shows how the fund performs relative to the Sectoral / Thematic category average. Positive values indicate outperformance, while negative values show underperformance.
Compare with similar funds in Sectoral / Thematic category
| Fund Name | NAV | 1M | 3M | 6M |
|---|---|---|---|---|
| Aditya Birla SL MNC Fund - Direct (G) | ₹1524.25 | 3.51% | 14.28% | 3.38% |
| Aditya Birla SL MNC Fund - (G) | ₹1370.22 | 3.45% | 14.08% | 3.04% |
| Nippon India Banking&Financial Services-Dir(Bonus) | ₹702.57 | 4.13% | 14.57% | 15.30% |
| Nippon India Banking&Financial Services-Dir(G) | ₹702.57 | 4.13% | 14.57% | 15.30% |
| Nippon India Banking&Financial Services (Bonus) | ₹643.19 | 4.05% | 14.33% | 14.82% |
| Nippon India Banking&Financial Services (G) | ₹643.19 | 4.05% | 14.33% | 14.82% |
| Nippon India Pharma Fund - Direct (Bonus) | ₹575.71 | 2.71% | 9.40% | -1.82% |
| Nippon India Pharma Fund - Direct (G) | ₹575.71 | 2.71% | 9.40% | -1.82% |
| Franklin India Technology Fund - Direct (G) | ₹575.22 | 4.81% | 11.95% | -4.25% |
| ICICI Pru FMCG Fund - Direct (G) | ₹523.66 | 0.36% | 5.43% | 1.39% |
A seasoned investment professional with over 1 years of experience in equity research and fund management. Known for consistent performance and a disciplined investment approach focused on quality growth stocks.